Free Trial
NYSE:CPHI

China Pharma (CPHI) Stock Price, News & Analysis

China Pharma logo
$1.90 +0.06 (+3.42%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$1.92 +0.02 (+0.89%)
As of 07/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About China Pharma Stock (NYSE:CPHI)

Key Stats

Today's Range
$1.72
$1.94
50-Day Range
$1.52
$2.35
52-Week Range
$1.20
$3.35
Volume
28,417 shs
Average Volume
78,153 shs
Market Capitalization
$6.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

China Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

CPHI MarketRank™: 

China Pharma scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for China Pharma.

  • Price to Book Value per Share Ratio

    China Pharma has a P/B Ratio of 2.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.27% of the float of China Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    China Pharma has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in China Pharma has recently increased by 3.61%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    China Pharma does not currently pay a dividend.

  • Dividend Growth

    China Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.27% of the float of China Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    China Pharma has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in China Pharma has recently increased by 3.61%, indicating that investor sentiment is decreasing.
  • News Sentiment

    China Pharma has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.
  • Insider Buying vs. Insider Selling

    In the past three months, China Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.32% of the stock of China Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about China Pharma's insider trading history.
Receive CPHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Pharma and its competitors with MarketBeat's FREE daily newsletter.

CPHI Stock News Headlines

China Pharma Holdings, Inc. (CPHI) - Yahoo Finance
CPHI China Pharma Holdings, Inc. - Seeking Alpha
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
See More Headlines

CPHI Stock Analysis - Frequently Asked Questions

China Pharma's stock was trading at $23.00 at the beginning of the year. Since then, CPHI shares have decreased by 91.7% and is now trading at $1.9030.

China Pharma Holdings, Inc. (NYSE:CPHI) posted its quarterly earnings results on Wednesday, August, 15th. The company reported ($100.00) EPS for the quarter. The company earned $3.17 million during the quarter. China Pharma had a negative trailing twelve-month return on equity of 63.93% and a negative net margin of 85.56%.

Shares of China Pharma reverse split before market open on Tuesday, April 15th 2025.The 1-10 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 14th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of CPHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that China Pharma investors own include iBio (IBIO), Biocept (BIOC), Micron Technology (MU), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP) and Bionano Genomics (BNGO).

Company Calendar

Last Earnings
8/15/2018
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:CPHI
CIK
1106644
Employees
250
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.08 million
Net Margins
-85.56%
Pretax Margin
-85.56%
Return on Equity
-63.93%
Return on Assets
-31.42%

Debt

Debt-to-Equity Ratio
0.22
Current Ratio
0.79
Quick Ratio
0.26

Sales & Book Value

Annual Sales
$4.30 million
Price / Sales
1.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.70 per share
Price / Book
2.72

Miscellaneous

Outstanding Shares
3,262,000
Free Float
15,918,000
Market Cap
$6.21 million
Optionable
Not Optionable
Beta
0.79
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:CPHI) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners